{"organizations": [], "uuid": "6bf941a952d1a8b437389b96ec9f8c082e40fe83", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-nestle-health-science-us-holdings/brief-nestle-health-science-us-holdings-inc-reports-16-97-pct-stake-in-seres-therapeutics-inc-idUSFWN1RO0FY", "country": "US", "domain_rank": 408, "title": "BRIEF-Nestle Health Science Us Holdings, Inc Reports 16.97 Pct Stake In Seres Therapeutics Inc", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-11T13:29:00.000+03:00", "replies_count": 0, "uuid": "6bf941a952d1a8b437389b96ec9f8c082e40fe83"}, "author": "", "url": "https://www.reuters.com/article/brief-nestle-health-science-us-holdings/brief-nestle-health-science-us-holdings-inc-reports-16-97-pct-stake-in-seres-therapeutics-inc-idUSFWN1RO0FY", "ord_in_thread": 0, "title": "BRIEF-Nestle Health Science Us Holdings, Inc Reports 16.97 Pct Stake In Seres Therapeutics Inc", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-nestle health science us holdings", "sentiment": "negative"}, {"name": "seres therapeutics inc reuters", "sentiment": "negative"}, {"name": "inc", "sentiment": "negative"}, {"name": "seres therapeutics inc  nestle health science us holdings", "sentiment": "neutral"}, {"name": "sec", "sentiment": "none"}, {"name": "nestle health science us holdings", "sentiment": "none"}, {"name": "seres therapeutics inc", "sentiment": "none"}, {"name": "min read    seres therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " Nestle Health Science Us Holdings, Inc Reports 16.97 Pct Stake In Seres Therapeutics Inc Reuters Staff 1 Min Read \n  Seres Therapeutics Inc: \n* Nestle Health Science Us Holdings, Inc Reports 16.97 Pct Stake In Seres Therapeutics Inc As Of April 10, 2018 - SEC Filing Source text ( bit.ly/2GSzKlq )  ", "external_links": [], "published": "2018-04-11T13:29:00.000+03:00", "crawled": "2018-04-11T13:52:53.001+03:00", "highlightTitle": ""}